drugset / Trial / NCT05252754

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

NCT05252754

Phase 3 Recruiting 4874 enrolled Johns Hopkins University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This research is being done to see if using oral tacrolimus before endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).

Timeline

Start
2023-01-18
Primary completion
2026-12
Completion
2026-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 5 mg Oral
Background Indomethacin Small molecule 100 mg Rectal

Indications